The Fingerland Department of Pathology ****************************************************************************************** * ****************************************************************************************** The department was established in 1928 and provides a full range of necropsy, biopsy and c diagnostic services. The Institute includes laboratories for biopsy, cytology, immunohisto electron microscopy, in situ hybridization and molecular pathology. Special scientific and focus of the department: cardiovascular pathology, haematopathology, head and neck patholo stomatopathology, gynaecopathology, thyroid pathology, breast pathology, central nervous s neuroendocrine system pathology. The institute is a teaching centre of the Faculty of Medi University in Hradec Králové and teaches bachelor, master (general medicine and dentistry) study programmes (pathology) in Czech and English. ****************************************************************************************** * Main research topics ****************************************************************************************** • New predictive markers for solid malignancies and haemato-oncological diseases. • Etiopathogenesis of precancerous and malignant tumors of the head and neck and female ge • New differential diagnostic and predictive markers in central nervous system and pituita neuroendocrine tumors. ****************************************************************************************** * Scientific research groups ****************************************************************************************** • Group for research of predictive markers in cancer (prof. MUDr. Aleš Ryška, Ph.D. [ URL is.cuni.cz/webapps/whois2/osoba/1024820499648708/?lang=cs"] ); focus on research of new markers in breast cancer, lung cancer and colon cancer in order to improve the possibili personalized medicine • Head and Neck and Female Genital System Cancers Research Group (prof. MUDr. Jan Laco, Ph [ URL "https://is.cuni.cz/webapps/whois2/osoba/1678829875027853/?lang=cs"] );focus on re etiopathogenesis of sinonasal, pharyngeal and salivary gland cancers, focus on molecular characteristics of ovarian, uterine mucosa, cervix and vulva cancer; research on interac cancer and immune system • Central nervous system and pituitary and neuroendocrine tumours research group (MUDr. Ji [ URL "https://is.cuni.cz/webapps/whois2/osoba/1397825735308600/?lang=cs"] ); focus on r new differential diagnostic and prognostic immunohistochemical and molecular genetic mar tumours ****************************************************************************************** * Equipment ****************************************************************************************** • Multiparallel Sequencing System - NGS technology enables detection and multiple comparis point mutations (SNVs), deletions, insertions, copy number variations (CNVs) and structu used for comprehensive molecular profiling of solid tumors • Cyclers for real-time PCR - highly sensitive method for qualitative mutational analysis, targeted detection of variants in paraffin-fixed tumour tissue or in freely circulating blood plasma • Tissue microarray- TMA-technology enables very efficient high-throughput pathology, wher is cut out from a donor tissue block under microscopic control and then transferred to a block. Expression profiles of up to several hundred samples can be monitored in a single with significant savings in reagents and time during readout ****************************************************************************************** * Achievements ****************************************************************************************** • 2022-2023 - prof. MUDr. Aleš Ryška, Ph.D. [ URL "https://is.cuni.cz/webapps/whois2/ osoba/1024820499648708/?lang=cs"] , President of the European Society of Pathologists • 2022 - prof. MUDr. Jan Laco, Ph.D. [ URL "https://is.cuni.cz/webapps/whois2/osoba/167882 lang=cs"] , became one of the co-authors of the 5th edition of the WHO classification of cancer The institute operates a biological material bank, which is involved in the Czech part of distributed research infrastructure of pan-European importance - BBMRI (Biobanking and Bio Resources Research Infrastructure), which aims to create and operate a network of biologic for biomedical research. The biobank primarily holds native tumour tissue for future genom analysis for diagnostic, prognostic, predictive and research purposes.